Prognos Health
PrivateLast Round
Growth Equity
May 11, 2023
Est. Valuation
$58.8M
Total Funding Raised
$65.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Prognos Health operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Growth Equity round in May 2023.
Prognos Health is a healthcare technology company that operates a real-world data marketplace and an AI-powered platform to provide clinical insights from harmonized lab and health records for the life sciences industry.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Data Integration, Clinical Trials, Business Intelligence
Business Model
B2B
Customer Profile
Data as a Service, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Prognos Health Comparables
Compare Prognos Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HealthVerity | 87% | |
| OM1 | 82% | |
| Komodo Health | 81% |
For institutional investors. Book with your work email.
Prognos Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | May 11, 2023 | ||||
| Series C | Nov 30, 2017 | ||||
| Series B | Jun 18, 2013 | ||||
| Series A | Nov 17, 2011 | ||||
| Angel | Jan 1, 2010 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Prognos Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GIS Strategic Ventures | Series C |
| Hunt Holdings | Growth Equity |
| Cigna Ventures | Growth Equity |
| Hermed Capital | Series C |
| Red & Blue Ventures | Growth Equity |
| Safeguard Scientifics | Series B, Growth Equity, Series C, Series A |
| MentorTech Ventures | Series B, Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 36% MoM, reaching 4.1K.
- May 11, 2023
$23M round led by Marshall Wace and Safeguard Scientifics.
For institutional investors. Book with your work email.
Prognos Health Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Prognos Health's valuation, stock price, and market status.
Is Prognos Health a public or private company?
Prognos Health is a private company.
What is the current stock price of Prognos Health?
Prognos Health is a private company, so its shares have no public market price. Caplight tracks Prognos Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Prognos Health worth (valuation)?
Prognos Health's valuation is estimated at $58.8M based on funding round data.
Can I buy Prognos Health stock?
Prognos Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Prognos Health's last funding round?
Prognos Health's most recent funding round was Growth Equity on May 11, 2023.
Who are the main investors in Prognos Health?
Key investors in Prognos Health include Safeguard Scientifics, Marshall Wace.
Will Prognos Health IPO soon?
No public IPO plans have been announced for Prognos Health.
How can I track Prognos Health secondary market activity?
Caplight tracks bids, offers, and trades in Prognos Health's shares on secondary markets.